Impact of schizophrenia genetic liability on the association between schizophrenia and physical illness: a data linkage study

Kendall, Kimberley M. ORCID: https://orcid.org/0000-0002-6755-6121, John, Ann, Lee, Sze Chim, Rees, Elliott ORCID: https://orcid.org/0000-0002-6168-9222, Pardiñas, Antonio F. ORCID: https://orcid.org/0000-0001-6845-7590, Del Pozo Banos, Marcos, Owen, Michael J. ORCID: https://orcid.org/0000-0003-4798-0862, O’Donovan, Michael C. ORCID: https://orcid.org/0000-0001-7073-2379, Kirov, George ORCID: https://orcid.org/0000-0002-3427-3950, Lloyd, Keith, Jones, Ian ORCID: https://orcid.org/0000-0001-5821-5889, Legge, Sophie E. and Walters, James T. R. ORCID: https://orcid.org/0000-0002-6980-4053 2020. Impact of schizophrenia genetic liability on the association between schizophrenia and physical illness: a data linkage study. BJPsych Open 6 (6) , e139. 10.1192/bjo.2020.42

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (515kB) | Preview

Abstract

Background Individuals with schizophrenia are at higher risk of physical illnesses, which are a major contributor to their 20-year reduced life expectancy. It is currently unknown what causes the increased risk of physical illness in schizophrenia. Aims To link genetic data from a clinically ascertained sample of individuals with schizophrenia to anonymised NHS records. To assess (i) rates of physical illness in those with schizophrenia, and (ii) whether physical illness in schizophrenia is associated with genetic liability. Method We linked genetic data from a clinically ascertained sample of individuals with schizophrenia (CardiffCOGS, n=896) to anonymised NHS records held in the Secure Anonymised Information Linkage (SAIL) databank. Physical illnesses were defined from the General Practice Database and Patient Episode Database for Wales. Genetic liability for schizophrenia was indexed by (i) rare CNVs, and (ii) polygenic risk scores. Results Individuals with schizophrenia in SAIL had increased rates of epilepsy (standardised rate ratio (SRR)=5.34), intellectual disability (SRR=3.11), type 2 diabetes (SRR=2.45), congenital disorders (SRR=1.77), ischaemic heart disease (SRR=1.57) and smoking (SRR=1.44) in comparison to the general SAIL population. In those with schizophrenia, carrier status for schizophrenia-associated CNVs and neurodevelopmental disorderassociated CNVs was associated with height (P=0.015–0.017), with carriers being 7.5– 7.7cm shorter than non-carriers. We did not find evidence that the increased rates of poor physical health outcomes in schizophrenia are associated with genetic liability for the disorder. Conclusions This study demonstrates the value of and potential for linking genetic data from clinically ascertained research studies to anonymised health records. The increased risk

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Medicine
Publisher:	Cambridge University Press
ISSN:	2056-4724
Funders:	Wellcome Trust, MRC
Date of First Compliant Deposit:	19 June 2020
Date of Acceptance:	1 May 2020
Last Modified:	09 May 2023 22:11
URI:	https://orca.cardiff.ac.uk/id/eprint/132639

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item